Previous studies have revealed that tBHQ plays a protective role against hypoxic–ischemic brain damage (38), cisplatin-induced nephrotoxicity (39), and hepatic ischemia/reperfusion (I/R) injury (40) by activating Nrf2-mediated antioxidative signaling pathways. Here, NFE2L2 is linked to ischemia.